Page Agata, Mann Derek A, Mann Jelena
Institute of Cellular Medicine, Faculty of Medical Sciences, 4 Floor, William Leech Building, Newcastle University, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK.
Curr Pathobiol Rep. 2014 Dec;2(4):163-170. doi: 10.1007/s40139-014-0052-0. Epub 2014 Sep 27.
Epigenetics is a dynamically expanding field of science entailing numerous regulatory mechanisms controlling changes of gene expression in response to environmental factors. Over the recent years there has been a great interest in epigenetic marks as a potential diagnostic and prognostic tool or future target for treatment of various human diseases. There is an increasing body of published research to suggest that epigenetic events regulate progression of chronic liver disease. Experimental manipulation of epigenetic signatures such as DNA methylation, histone acetylation / methylation and the activities of proteins that either annotate or interpret these epigenetic marks can have profound effects on the activation and phenotype of HSC, key cells responsible for onset and progression of liver fibrosis. This review presents recent advances in epigenetic alterations, which could provide mechanistic insight into the pathogenesis of chronic liver disease and provide novel clinical applications.
表观遗传学是一个动态发展的科学领域,涉及众多调控机制,这些机制控制着基因表达随环境因素的变化。近年来,表观遗传标记作为一种潜在的诊断和预后工具或各种人类疾病未来的治疗靶点,引发了人们极大的兴趣。越来越多已发表的研究表明,表观遗传事件调控着慢性肝病的进展。对表观遗传特征(如DNA甲基化、组蛋白乙酰化/甲基化以及注释或解读这些表观遗传标记的蛋白质的活性)进行实验性操控,可对肝星状细胞(HSC)的激活和表型产生深远影响,肝星状细胞是导致肝纤维化发生和进展的关键细胞。本综述介绍了表观遗传改变的最新进展,这可为深入了解慢性肝病的发病机制提供机制性见解,并提供新的临床应用。